Skip to main content
Log in

SiO2 prompts host defense against Acinetobacter baumannii infection by mTORC1 activation

  • Research Paper
  • Published:
Science China Life Sciences Aims and scope Submit manuscript

Abstract

Host-pathogen interactions in the setting of chronic pulmonary inflammation remain unclear, and the occurrence of pneumonia is increased in patients with chronic obstructive pulmonary disease who use immunosuppressive drugs. We performed Acinetobacter baumannii infection in mice with chronic pulmonary inflammation after intranasal administration of SiO2 and found SiO2 treatment increased host defense against A. baumannii infection. Innate immune responses initiated by NF-κB, type 1 interferon, NLRP3 and AIM2 inflammasomes were dispensable for SiO2-mediated host defense. SiO2 treatment activated the mTORC1 signaling, and mTORC1 was crucial for host defense against A. baumannii infection. Our study highlights the protective role of mTORC1 signaling in host defense against bacterial infection, offers novel insights into understanding the mechanisms of immunosuppressive drug-related pneumonia, and provides potential host-directed therapeutics to treat bacterial infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Albiges, L., Chamming’s, F., Duclos, B., Stern, M., Motzer, R.J., Ravaud, A., and Camus, P. (2012). Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. Ann Oncol 23, 1943–1953.

    Article  CAS  Google Scholar 

  • Boschetto, P., Quintavalle, S., Miotto, D., Lo Cascio, N., Zeni, E., and Mapp, C.E. (2006). Chronic obstructive pulmonary disease (COPD) and occupational exposures. J Occup Med Toxicol 1, 11.

    Article  Google Scholar 

  • Cho, Y.M., Lee, J.I., Choi, M., Choi, W.S., Myong, J.P., Kim, H.R., and Koo, J.W. (2015). Work-related COPD after years of occupational exposure. Ann Occup Environ Med 27, 6.

    Article  Google Scholar 

  • Cohen, R.A.C., Patel, A., and Green, F.H.Y. (2008). Lung disease caused by exposure to coal mine and silica dust. Semin Respir Crit Care Med 29, 651–661.

    Article  Google Scholar 

  • Courtwright, A.M., Goldberg, H.J., Henske, E.P., and El-Chemaly, S. (2017). The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis. Eur Respir Rev 26, 160004.

    Article  Google Scholar 

  • Cullinan, P. (2012). Occupation and chronic obstructive pulmonary disease (COPD). Br Med Bull 104, 143–161.

    Article  Google Scholar 

  • Dabydeen, D.A., Jagannathan, J.P., Ramaiya, N., Krajewski, K., Schutz, F. A.B., Cho, D.C., Pedrosa, I., and Choueiri, T.K. (2012). Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome. Eur J Cancer 48, 1519–1524.

    Article  CAS  Google Scholar 

  • Eliopoulos, G.M, Maragakis, L.L., and Perl, T.M. (2008). Antimicrobial resistance: Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46, 1254–1263.

    Article  Google Scholar 

  • Guo, C., Chi, Z., Jiang, D., Xu, T., Yu, W., Wang, Z., Chen, S., Zhang, L., Liu, Q., Guo, X., et al. (2018). Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity 49, 842–856.e7.

    Article  CAS  Google Scholar 

  • Hnizdo, E., and Vallyathan, V. (2003). Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med 60, 237–243.

    Article  CAS  Google Scholar 

  • Iijima, Y., Fujioka, N., Uchida, Y., Kobayashi, Y., Tsutsui, T., Kakizaki, Y., and Miyashita, Y. (2018). Invasive pulmonary aspergillosis mimicking organizing pneumonia after mTOR inhibitor therapy: A case report. Int J Infect Dis 69, 75–77.

    Article  Google Scholar 

  • Karki, R., Man, S.M., Malireddi, R.K.S., Kesavardhana, S., Zhu, Q., Burton, A.R., Sharma, B.R., Qi, X., Pelletier, S., Vogel, P., et al. (2016). NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature 540, 583–587.

    Article  CAS  Google Scholar 

  • Kim, J.H., Park, J.S., Kim, K.H., Jeong, H.C., Kim, E.K., and Lee, J.H. (2013). Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD. Chest 143, 1018–1024.

    Article  CAS  Google Scholar 

  • King, P.T., MacDonald, M., and Bardin, P.G. (2013). Bacteria in COPD; their potential role and treatmen. Transl Respir Med 1, 13.

    Article  Google Scholar 

  • Kraft, M. (2000). The role of bacterial infections in asthma. Clin Chest Med 21, 301–313.

    Article  CAS  Google Scholar 

  • Labaki, W.W., and Han, M.L.K. (2017). Antibiotics for COPD exacerbations. Lancet Respir Med 5, 461–462.

    Article  Google Scholar 

  • Li, F., Li, Y., Liang, H., Xu, T., Kong, Y., Huang, M., Xiao, J., Chen, X., Xia, H., Wu, Y., et al. (2018a). HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. J Clin Invest 128, 4148–4162.

    Article  Google Scholar 

  • Li, J., Kim, S.G., and Blenis, J. (2014). Rapamycin: one drug, many effects. Cell Metab 19, 373–379.

    Article  CAS  Google Scholar 

  • Li, Y., Guo, X., Hu, C., Du, Y., Guo, C., Di Wang, C., Zhao, W., Huang, G., Li, C., Lu, Q., et al. (2018b). Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection. Cell Death Differ 25, 1304–1318.

    Article  CAS  Google Scholar 

  • Man, S.M., and Kanneganti, T.D. (2016). Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol 16, 7–21.

    Article  CAS  Google Scholar 

  • Mehta, S., Shin, H., Burnett, R., North, T., and Cohen, A.J. (2013). Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease. Air Qual Atmos Health 6, 69–83.

    Article  CAS  Google Scholar 

  • Nedel, W.L., Nora, D.G., Salluh, J.I.F., Lisboa, T., and Póvoa, P. (2016). Corticosteroids for severe influenza pneumonia: A critical appraisal. World J Crit Care Med 5, 89–95.

    Article  Google Scholar 

  • Nhung, N.T.T., Schindler, C., Dien, T.M., Probst-Hensch, N., Perez, L., and Künzli, N. (2018). Acute effects of ambient air pollution on lower respiratory infections in Hanoi children: An eight-year time series study. Environ Int 110, 139–148.

    Article  Google Scholar 

  • Nishino, M., Boswell, E.N., Hatabu, H., Ghobrial, I.M., and Ramaiya, N.H. (2015). Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy: Radiographic pattern-based approach in Waldenström macroglobulinemia as a paradigm. Oncologist 20, 1077–1083.

    Article  CAS  Google Scholar 

  • Park, H.J., Sohn, J.H., Kim, Y.J., Park, Y.H., Han, H., Park, K.H., Lee, K., Choi, H., Um, K., Choi, I.H., et al. (2015). Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics. Exp Mol Med 47, e173.

    Article  CAS  Google Scholar 

  • Qi, X., Gurung, P., Malireddi, R.K.S., Karmaus, P.W.F., Sharma, D., Vogel, P., Chi, H., Green, D.R., and Kanneganti, T.D. (2017). Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol 10, 128–138.

    Article  CAS  Google Scholar 

  • Qi, X., Hong, J., Chaves, L., Zhuang, Y., Chen, Y., Wang, D., Chabon, J., Graham, B., Ohmori, K., Li, Y., et al. (2013). Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates. Immunity 39, 97–110.

    Article  CAS  Google Scholar 

  • Rinne, S.T., Wiener, R.S., Chen, Y., Rise, P., Udris, E., Feemster, L.C., and Au, D.H. (2018). Impact of guideline changes on indications for inhaled corticosteroids among veterans with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 198, 1226–1228.

    Article  Google Scholar 

  • Sethi, S. (2010). Infection as a comorbidity of COPD. Eur Respir J 35, 1209–1215.

    Article  CAS  Google Scholar 

  • Sethi, S., and Murphy, T.F. (2001). Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 14, 336–363.

    Article  CAS  Google Scholar 

  • Sethi, S., and Murphy, T.F. (2008). Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359, 2355–2365.

    Article  CAS  Google Scholar 

  • Shi, C., and Pamer, E.G. (2011). Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11, 762–774.

    Article  CAS  Google Scholar 

  • Singh, S., Amin, A.V., and Loke, Y.K. (2009). Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease. Arch Intern Med 169, 219–229.

    Article  Google Scholar 

  • Sykes, A., and Johnston, S.L. (2008). Etiology of asthma exacerbations. J Allergy Clin Immunol 122, 685–688.

    Article  Google Scholar 

  • Thakur, S.A., Beamer, C.A., Migliaccio, C.T., and Holian, A. (2009). Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicol Sci 108, 462–471.

    Article  CAS  Google Scholar 

  • van Velzen, P., ter Riet, G., Bresser, P., Baars, J.J., van den Berg, B.T.J., van den Berg, J.W.K., Brinkman, P., Dagelet, J.W.F., Daniels, J.M.A., Groeneveld-Tjiong, D.R.G.L., et al. (2017). Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. Lancet Respir Med 5, 492–499.

    Article  CAS  Google Scholar 

  • Vollenweider, D.J., Frei, A., Steurer-Stey, C.A., Garcia-Aymerich, J., and Puhan, M.A. (2018). Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 10.

  • Weichhart, T., Hengstschläger, M., and Linke, M. (2015). Regulation of innate immune cell function by mTOR. Nat Rev Immunol 15, 599–614.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Key Research and Development Program of China (2017YFD0500300), the National Natural Science Foundation of China (31970896, 31701134 and 81701578) and Yunnan Province (2019FJ008, 2018FA038, 2018FB127, 2018FB131, HXDTZX-2019-1, HXDT-2019-2, and AMHD-2018-2). We thank F. Shao (National Institute of Biological Sciences, Beijing) for Ifnar−/− and Aim2−/− mice; and D. Wang (Zhejiang University) for Nlrp3−/− mice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaopeng Qi.

Additional information

Compliance and ethics

The author(s) declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, X., Wang, C., Xu, T. et al. SiO2 prompts host defense against Acinetobacter baumannii infection by mTORC1 activation. Sci. China Life Sci. 64, 982–990 (2021). https://doi.org/10.1007/s11427-020-1781-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-020-1781-8

Navigation